Robert Benjamin Stein - 28 Jun 2022 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

SEC evidence 5 source fields
Form type
4
Accepted by SEC
30 Jun 2022, 19:09:21 UTC
Previous filing
12 Apr 2022
Next filing
08 Aug 2022
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ William F. Hulse as attorney in fact for Robert Benjamin Stein

Key filing fact

Robert Benjamin Stein filed Form 4 for MIMEDX GROUP, INC. (MDXG) on 30 Jun 2022.

Key facts

  • This page summarizes Robert Benjamin Stein's Form 4 filing for MIMEDX GROUP, INC. (MDXG).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Jun 2022, 19:09.

Change

  • Previous filing in this sequence was filed on 12 Apr 2022.
  • Current net transaction value: -$50,662.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDXG transaction

Common Stock

Sale

Transaction value
$50,662
Shares
-14,600
Change %
-4.2%
Price
$3.47
Shares after
334,005
Date
28 Jun 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.47 to $3.48, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .